Morningstar and Bailleau brokers both still have AXA as a strong buy. Dunno why though. This stock has been putrid recently.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025